|
US 12,391,729 B2 |
|
| Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria |
| Brian Thompson, Creve Coeur, MO (US); and Ashley Siegel, St. Louis, MO (US) |
| Assigned to Spogen Biotech Inc., St. Louis, MO (US) |
| Filed by Spogen Biotech Inc., St. Louis, MO (US) |
| Filed on Dec. 28, 2023, as Appl. No. 18/398,650. |
| Application 18/398,650 is a division of application No. 17/079,942, filed on Oct. 26, 2020, granted, now 11,905,315. |
| Application 16/563,086 is a division of application No. 15/842,062, filed on Dec. 14, 2017, granted, now 10,407,472, issued on Sep. 10, 2019. |
| Application 17/079,942 is a continuation of application No. 16/563,086, filed on Sep. 6, 2019, granted, now 10,836,800, issued on Nov. 17, 2020. |
| Application 15/842,062 is a continuation of application No. 14/857,606, filed on Sep. 17, 2015, granted, now 9,845,342, issued on Dec. 19, 2017. |
| Claims priority of provisional application 62/051,885, filed on Sep. 17, 2014. |
| Prior Publication US 2024/0199709 A1, Jun. 20, 2024 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A01H 3/00 (2006.01); A01N 37/44 (2006.01); A01N 63/10 (2020.01); A01N 63/50 (2020.01); A23K 20/147 (2016.01); A61L 2/18 (2006.01); C02F 3/34 (2023.01); C07K 14/32 (2006.01); C09K 8/62 (2006.01); C12N 1/20 (2006.01); C12N 3/00 (2006.01); C12N 15/62 (2006.01); C12N 15/75 (2006.01); C12P 21/02 (2006.01); E21B 43/16 (2006.01); A01N 63/20 (2020.01); A23K 10/18 (2016.01); A61K 39/00 (2006.01); C02F 101/10 (2006.01); C02F 101/30 (2006.01); C02F 103/00 (2006.01); C02F 103/06 (2006.01); C02F 103/10 (2006.01); C02F 103/14 (2006.01); C02F 103/16 (2006.01); C02F 103/26 (2006.01); C02F 103/28 (2006.01) |